Effects of ONO-2506PO in Patients With Alzheimer's Disease
NCT ID: NCT00083421
Last Updated: 2012-06-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
647 participants
INTERVENTIONAL
2004-06-30
2007-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease
NCT06881836
Study to Evaluate DNL747 in Subjects With Alzheimer's Disease
NCT03757325
Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease
NCT00722046
Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease
NCT02322021
A Study of ATH-1017 in Mild to Moderate Alzheimer's Disease
NCT04491006
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ONO-2506PO
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Standardized MMSE Score of 13 to 24 points (inclusive)
* Modified Hachinski score equal or less than 4
Exclusion Criteria
* Other illnesses that may include dementive features
50 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ono Pharma USA Inc
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kirkland Clinic
Birmingham, Alabama, United States
Alzheimers Disease Research Center
Birmingham, Alabama, United States
Pivotal Research Center
Mesa, Arizona, United States
HOPE Research Institute
Phoenix, Arizona, United States
Sun Health Research Institute
Sun City, Arizona, United States
University of Arizona
Tucson, Arizona, United States
Margolin Brain Institute
Fresno, California, United States
UCI Medical Center Neuropsychiatric Center
Orange, California, United States
Pacific Neuroscience Medical Group
Oxnard, California, United States
The Southwest Institute for Clinical Research, Inc
Rancho Mirage, California, United States
Hamid Rabiee, MD
Redding, California, United States
Alzheimers Disease Research Center, Univ of CA, San Diego
San Diego, California, United States
Pacific Research Network
San Diego, California, United States
San Francisco Clinical Research Center
San Francisco, California, United States
Apex Research Institute
Santa Ana, California, United States
Pacific Neuroscience Medical Group
Santa Barbara, California, United States
Neurological Research Institute
Santa Monica, California, United States
Radiant Research
Denver, Colorado, United States
Research Center for Clinical Studies, Inc.
Darien, Connecticut, United States
GAP Clinical Care & Research Center
Hamden, Connecticut, United States
Baumel-Eisner Neuromedical Institute
Boca Raton, Florida, United States
Neurologic Consultants
Fort Lauderdale, Florida, United States
Baumel-Eisner Neuromedical Institute
Fort Lauderdale, Florida, United States
Gainsville Open MRI
Gainsville, Florida, United States
Berma Research Group
Hialeah, Florida, United States
Miami Jewish and Hospital for the Aged
Miami, Florida, United States
Baumel-Eisner Neuromedical Institute
Miami Beach, Florida, United States
Palm Beach Neurological Center
Palm Beach Gardens, Florida, United States
Research Site
Port Charlotte, Florida, United States
Suncoast Neuroscience Associates
St. Petersburg, Florida, United States
Meridien Research
St. Petersburg, Florida, United States
Axiom Clinical Research of Florida
Tampa, Florida, United States
Johnnie B. Byrd Sr. Alzheimer's Center and Research Institute
Tampa, Florida, United States
Premiere Research Institute
West Palm Beach, Florida, United States
DeKalb Neurology Associates
Atlanta, Georgia, United States
Emory University
Atlanta, Georgia, United States
Mercer University
Atlanta, Georgia, United States
Rush Alzheimers Disease Center
Chicago, Illinois, United States
University of Illinois at Chicago
Chicago, Illinois, United States
Radiant Research
Hoffman Estates, Illinois, United States
Southern Illinois School of Medicine
Springfield, Illinois, United States
Fort Wayne Neurological Center
Fort Wayne, Indiana, United States
Center for Alzheimers Disease and Related Disorders
Indianapolis, Indiana, United States
Agewell
Indianapolis, Indiana, United States
Louisiana State University Health Sciences Cntr - Dept of Psychiatry
New Orleans, Louisiana, United States
J. Gary Booker, M.D., APMC
Shreveport, Louisiana, United States
St. Louis University Medical Center
St Louis, Missouri, United States
University of Nevada
Las Vegas, Nevada, United States
Mid Atlantic Geriatric Association
Ocean Township, New Jersey, United States
Meridian Institue for Aging
Paterson, New Jersey, United States
St. Francis Medical Center
Trenton, New Jersey, United States
Upstate Clinical Reserach, LLC
Albany, New York, United States
Upstate Neurology Consults, LLP
Albany, New York, United States
Neurological Associates of Albany
Albany, New York, United States
Neurobehavioral Research Inc.
Lawrence, New York, United States
Eastside Comprehensive Medical Services
New York, New York, United States
Global Reserach & Consulting
Olean, New York, United States
Monroe Community Hospital
Rochester, New York, United States
Behavioral Medical Research
Staten Island, New York, United States
Duke University Medical Center
Durham, North Carolina, United States
Metrohealth Medical Center
Cleveland, Ohio, United States
Ohio State University Hospital
Columbus, Ohio, United States
Infinity Research Group, LLC
Oklahoma City, Oklahoma, United States
Clinical Pharmaceutical Trials
Tulsa, Oklahoma, United States
Medford Neurological and Spine Clinic
Medford, Oregon, United States
Summit Research Network
Portland, Oregon, United States
Oregon Health and Science University
Portland, Oregon, United States
Westmoreland Neurology Associates, Inc.
Greensburg, Pennsylvania, United States
University of PA, Section Geriatric Psychiatry
Philadelphia, Pennsylvania, United States
Alzheimer Disease Research Center, Univ of Pittsburg
Pittsburgh, Pennsylvania, United States
Miriam Hospital
Providence, Rhode Island, United States
Medical University of South Carolina, Alzheimers Research and Clinical Programs
North Charleston, South Carolina, United States
Claghorn Lesem Research Clinic
Bellaire, Texas, United States
Memory Research Unit, Univ of Texas Southwest Med Ctr at Dallas
Dallas, Texas, United States
Radiant Research San Antonio
San Antonio, Texas, United States
Neurological Consultants, PC
Bennington, Vermont, United States
Innovative Clinical Research Center
Alexandria, Virginia, United States
Medical College of Wisconsin, Department of Neurology
Milwaukee, Wisconsin, United States
Independent Psychiatric Consultants
Waukesha, Wisconsin, United States
Inova Health Research, Inc.
Kelowna, British Columbia, Canada
University of British Columbia Hospital
Vancouver, British Columbia, Canada
Davidson Memory Clinic
Moncton, New Brunswick, Canada
Parkwood Hospital, Geriatric Medicine
London, Ontario, Canada
SCO Health Centre
Ottawa, Ontario, Canada
Toronto Memory Program
Toronto, Ontario, Canada
Hopital Maisonneuve-Rosemont
Montreal, Quebec, Canada
Pasqua Hospital
Regina, Saskatchewan, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ONO-2506POU010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.